ethyl 3-{3-cyano-4-[((2R)-3-{[1,1-dimethyl-2-(2-naphthalenyl)-ethyl]amino}-2-hydroxypropyl)oxy]phenyl}propanoate hydrochloride | 1192845-62-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: ethyl 3-{3-cyano-4-[((2R)-3-{[1,1-dimethyl-2-(2-naphthalenyl)-ethyl]amino}-2-hydroxypropyl)oxy]phenyl}propanoate hydrochloride
• 英文别名: Benzenepropanoic acid,3-cyano-4-[(2R)-3-[[1,1-dimethyl-2-(2-naphthalenyl)ethyl]amino]-2-hydroxypropoxy]-,ethyl ester,(Hydrochloride) (1:1)；ethyl 3-[3-cyano-4-[(2R)-2-hydroxy-3-[(2-methyl-1-naphthalen-2-ylpropan-2-yl)amino]propoxy]phenyl]propanoate;hydrochloride
• CAS: 1192845-62-7
• 化学式: C₂₉H₃₄N₂O₄*ClH
• 分子量: 511.061
• InChiKey: IFWPZKFWNGLFCD-UFTMZEDQSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.98
• 重原子数：
  36
• 可旋转键数：
  13
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  91.6
• 氢给体数：
  3
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  ethyl 3-{3-cyano-4-[((2R)-3-{[1,1-dimethyl-2-(2-naphthalenyl)-ethyl]amino}-2-hydroxypropyl)oxy]phenyl}propanoate 在 盐酸 作用下， 以 乙醚 、 乙腈 为溶剂， 反应 0.33h， 生成 ethyl 3-{3-cyano-4-[((2R)-3-{[1,1-dimethyl-2-(2-naphthalenyl)-ethyl]amino}-2-hydroxypropyl)oxy]phenyl}propanoate hydrochloride
  参考文献：
  名称：

  Antagonists of the Calcium Receptor. 2. Amino Alcohol-Based Parathyroid Hormone Secretagogues

  摘要：

  When administered as a single agent to rats the previously reported calcium receptor antagonist 3 elicited a sustained elevation of plasma PTH resulting in no increase in overall bone mineral density. The lack of a bone building effect for analogue 3 was attributed to the large volume of distribution (V-dss(rat) = 11 L/kg) producing a protracted plasma PTH profile. Incorporation of a carboxylic acid functionality into the amino alcohol template led to the identification of 12 with a lower volume of distribution (V-dss(12) = 1.18 L/kg) and a shorter half-life. The zwitterionic nature of antagonist 12 necessitated the utility of an ester prodrug approach to increase overall permeability. Antagonist 12 elicited a rapid and transient increase in circulating levels of PTH following oral dosing of the ester prodrug 11 in the dog. The magnitude and duration of the increases in plasma levels of PTH would be expected to stimulate new bone formation.

  DOI：

  10.1021/jm900563e